<p>根据公司在最近向证券交易委员会（SEC）提交的文件，Liberty Wealth Management LLC 在第四季度收购了 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的新股份。该基金收购了 4,079 股公司股票，价值约为 1,905,000 美元。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<ul>
<li>美国人口老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
<p>其他大型投资者也调整了对该公司的持股。国家养老金服务在第三季度将其在 HCA Healthcare 的持股比例提高了 2.9%。国家养老金服务目前拥有 626,585 股公司股票，价值 267,051,000 美元，此前在上个季度又收购了 17,531 股。Savant Capital LLC 在第三季度将其在 HCA Healthcare 的持股比例提高了 37.7%。Savant Capital LLC 目前拥有 4,548 股公司股票，价值 1,938,000 美元，此前在上个季度又收购了 1,246 股。Sector Gamma AS 在第三季度将其在 HCA Healthcare 的持股比例提高了 36.0%。Sector Gamma AS 目前拥有 10,883 股公司股票，价值 4,638,000 美元，此前在上个季度又收购了 2,883 股。Nordea Investment Management AB 在第四季度将其在 HCA Healthcare 的持股比例提高了 11.2%。Nordea Investment Management AB 目前拥有 1,084,590 股公司股票，价值 507,393,000 美元，此前在上个季度又收购了 108,849 股。最后，AlphaQuest LLC 在第三季度将其在 HCA Healthcare 的持股比例提高了 2,855.2%。AlphaQuest LLC 目前拥有 5,999 股公司股票，价值 2,557,000 美元，此前在上个季度又收购了 5,796 股。对冲基金和其他机构投资者持有该公司 62.73% 的股票。</p>
<h2>华尔街分析师观点</h2>
<p>几位研究分析师对 HCA 股票发布了报告。KeyCorp 在 4 月 27 日的研究报告中将 HCA Healthcare 的目标价从 550.00 美元下调至 510.00 美元，并对该公司给予 “增持” 评级。高盛集团在 1 月 28 日的报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。Wall Street Zen 在 5 月 2 日的报告中将 HCA Healthcare 的评级从 “买入” 下调至 “持有”。Oppenheimer 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 540.00 美元下调至 520.00 美元，并对该股票给予 “跑赢大盘” 评级。最后，Leerink Partners 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 573.00 美元下调至 500.00 美元，并对该股票给予 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 517.82 美元。</p>
<ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
<p><strong>查看我们对 HCA Healthcare 的最新分析</strong></p>
<h2>HCA Healthcare 上涨 0.9%</h2>
<p>纽约证券交易所 HCA 周三开盘价为 430.11 美元。该公司的 50 日移动平均价格为 485.46 美元，200 日移动平均价格为 486.47 美元。HCA Healthcare, Inc.的 12 个月低点为 330.00 美元，12 个月高点为 556.52 美元。该公司的市值为 954.2 亿美元，市盈率为 14.79，市盈增长比率为 1.35，贝塔值为 1.18。</p>
<ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在 4 月 24 日最后发布了其财报。该公司报告本季度每股收益为 7.15 美元，低于共识预期的 7.19 美元（差额为 0.04 美元）。HCA Healthcare 的股本回报率为负 295.93%，净利润率为 8.89%。该公司的季度收入为 191.1 亿美元，而分析师的预期为 190.9 亿美元。在去年同期，该公司每股收益为 6.45 美元。该公司的季度收入较去年同期增长了 4.3%。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。股票分析师预测 HCA Healthcare, Inc.在当前年度将发布 30.07 每股收益。</p>
<h2>HCA Healthcare 股息公告</h2>
<p>该公司最近还披露了一项季度股息，将于 6 月 30 日（星期二）支付。6 月 16 日（星期二）的股东将获得 0.78 美元的股息。这相当于年化 3.12 美元的股息和 0.7% 的股息收益率。除息日期为 6 月 16 日（星期二）。HCA Healthcare 的股息支付比率（DPR）为 10.73%。</p>
<h2>HCA Healthcare 内部活动</h2>
<p>在其他消息中，执行副总裁 Michael R. Mcalevey 在 2 月 18 日（星期三）出售了 1,694 股公司的股票。该股票以 533.37 美元的平均价格出售，总价值为 903,528.78 美元。交易后，该执行副总裁直接持有公司 8,853 股，价值 4,721,924.61 美元。此交易代表其持股比例减少了 16.06%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士目前持有 1.50% 的股票。</p>
<h2>HCA Healthcare 公司简介</h2>
<p>（免费报告）</p>
<p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
<p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 HCA Healthcare</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河系第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
<p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

医疗业 ETF - Vanguard

标普医疗保健服务 ETF - SPDR

美国医疗保健供应商 ETF - iShares

标普全球医疗股指数 ETF - iShares

医疗业 ETF - SPDR

<p>根据 SEC 的文件，Liberty Wealth Management LLC 在第四季度收购了 4,079 股 HCA Healthcare, Inc.（纽约证券交易所代码：HCA），价值约 190 万美元。其他投资者，包括国家养老金服务和 Savant Capital LLC，也增加了在 HCA 的持股。分析师对 HCA 的评级意见不一，普遍评级为 “适度买入”，平均目标价为 517.82 美元。HCA 的股票开盘价为 430.11 美元，市值为 954.2 亿美元。该公司最近报告每股收益为 7.15 美元，略低于预期，并宣布季度股息为 0.78 美元</p>

<p>Liberty Wealth Management LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 4,079 shares of the company's stock, valued at approximately $1,905,000.</p>
<div class="lb-trans"><p>根据公司在最近向证券交易委员会（SEC）提交的文件，Liberty Wealth Management LLC 在第四季度收购了 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的新股份。该基金收购了 4,079 股公司股票，价值约为 1,905,000 美元。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><ul>
<li>The Aging of America Could Make HCA Healthcare a Long-Term Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>美国人口老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
</div><p>Other large investors have also modified their holdings of the company. National Pension Service raised its position in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company's stock worth $267,051,000 after acquiring an additional 17,531 shares in the last quarter. Savant Capital LLC raised its position in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company's stock worth $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Sector Gamma AS raised its position in HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company's stock worth $4,638,000 after acquiring an additional 2,883 shares in the last quarter. Nordea Investment Management AB raised its position in HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company's stock worth $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Finally, AlphaQuest LLC raised its position in HCA Healthcare by 2,855.2% in the third quarter. AlphaQuest LLC now owns 5,999 shares of the company's stock worth $2,557,000 after acquiring an additional 5,796 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者也调整了对该公司的持股。国家养老金服务在第三季度将其在 HCA Healthcare 的持股比例提高了 2.9%。国家养老金服务目前拥有 626,585 股公司股票，价值 267,051,000 美元，此前在上个季度又收购了 17,531 股。Savant Capital LLC 在第三季度将其在 HCA Healthcare 的持股比例提高了 37.7%。Savant Capital LLC 目前拥有 4,548 股公司股票，价值 1,938,000 美元，此前在上个季度又收购了 1,246 股。Sector Gamma AS 在第三季度将其在 HCA Healthcare 的持股比例提高了 36.0%。Sector Gamma AS 目前拥有 10,883 股公司股票，价值 4,638,000 美元，此前在上个季度又收购了 2,883 股。Nordea Investment Management AB 在第四季度将其在 HCA Healthcare 的持股比例提高了 11.2%。Nordea Investment Management AB 目前拥有 1,084,590 股公司股票，价值 507,393,000 美元，此前在上个季度又收购了 108,849 股。最后，AlphaQuest LLC 在第三季度将其在 HCA Healthcare 的持股比例提高了 2,855.2%。AlphaQuest LLC 目前拥有 5,999 股公司股票，价值 2,557,000 美元，此前在上个季度又收购了 5,796 股。对冲基金和其他机构投资者持有该公司 62.73% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several research analysts have issued reports on HCA shares. KeyCorp cut their price objective on HCA Healthcare from $550.00 to $510.00 and set an &#34;overweight&#34; rating for the company in a research report on Monday, April 27th. The Goldman Sachs Group upped their target price on HCA Healthcare from $520.00 to $558.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, January 28th. Wall Street Zen lowered HCA Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, May 2nd. Oppenheimer lowered their target price on HCA Healthcare from $540.00 to $520.00 and set an &#34;outperform&#34; rating on the stock in a report on Monday, April 27th. Finally, Leerink Partners lowered their target price on HCA Healthcare from $573.00 to $500.00 and set an &#34;outperform&#34; rating on the stock in a report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $517.82.</p>
<div class="lb-trans"><p>几位研究分析师对 HCA 股票发布了报告。KeyCorp 在 4 月 27 日的研究报告中将 HCA Healthcare 的目标价从 550.00 美元下调至 510.00 美元，并对该公司给予 “增持” 评级。高盛集团在 1 月 28 日的报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。Wall Street Zen 在 5 月 2 日的报告中将 HCA Healthcare 的评级从 “买入” 下调至 “持有”。Oppenheimer 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 540.00 美元下调至 520.00 美元，并对该股票给予 “跑赢大盘” 评级。最后，Leerink Partners 在 4 月 27 日的报告中将 HCA Healthcare 的目标价从 573.00 美元下调至 500.00 美元，并对该股票给予 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 517.82 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
</div><p><strong>Check Out Our Latest Analysis on HCA Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们对 HCA Healthcare 的最新分析</strong></p>
</div><h2>HCA Healthcare Trading Up 0.9%</h2>
<div class="lb-trans"><h2>HCA Healthcare 上涨 0.9%</h2>
</div><p>NYSE HCA opened at $430.11 on Wednesday. The business's 50-day moving average price is $485.46 and its 200 day moving average price is $486.47. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a market capitalization of $95.42 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.35 and a beta of 1.18.</p>
<div class="lb-trans"><p>纽约证券交易所 HCA 周三开盘价为 430.11 美元。该公司的 50 日移动平均价格为 485.46 美元，200 日移动平均价格为 486.47 美元。HCA Healthcare, Inc.的 12 个月低点为 330.00 美元，12 个月高点为 556.52 美元。该公司的市值为 954.2 亿美元，市盈率为 14.79，市盈增长比率为 1.35，贝塔值为 1.18。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. During the same quarter last year, the company posted $6.45 earnings per share. The business's quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）在 4 月 24 日最后发布了其财报。该公司报告本季度每股收益为 7.15 美元，低于共识预期的 7.19 美元（差额为 0.04 美元）。HCA Healthcare 的股本回报率为负 295.93%，净利润率为 8.89%。该公司的季度收入为 191.1 亿美元，而分析师的预期为 190.9 亿美元。在去年同期，该公司每股收益为 6.45 美元。该公司的季度收入较去年同期增长了 4.3%。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。股票分析师预测 HCA Healthcare, Inc.在当前年度将发布 30.07 每股收益。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 股息公告</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 10.73%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度股息，将于 6 月 30 日（星期二）支付。6 月 16 日（星期二）的股东将获得 0.78 美元的股息。这相当于年化 3.12 美元的股息和 0.7% 的股息收益率。除息日期为 6 月 16 日（星期二）。HCA Healthcare 的股息支付比率（DPR）为 10.73%。</p>
</div><h2>Insider Activity at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 内部活动</h2>
</div><p>In other news, EVP Michael R. Mcalevey sold 1,694 shares of the firm's stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This trade represents a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，执行副总裁 Michael R. Mcalevey 在 2 月 18 日（星期三）出售了 1,694 股公司的股票。该股票以 533.37 美元的平均价格出售，总价值为 903,528.78 美元。交易后，该执行副总裁直接持有公司 8,853 股，价值 4,721,924.61 美元。此交易代表其持股比例减少了 16.06%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士目前持有 1.50% 的股票。</p>
</div><h2>HCA Healthcare Company Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 HCA Healthcare</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河系第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Liberty Wealth Management LLC 收购了 4,079 股 HCA 控股公司的股票，代码为$HCA